People who regularly use marijuana experience changes in their brain structure and function, but it's not clear that cannabis ...

Oct. 2, 2024 — Researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana's main ingredient, THC, reduces agitation in ... Cannabinoid CBG Reduces ...

It's time to end the War on Marijuana. The aggressive enforcement of marijuana possession laws needlessly ensnares hundreds of thousands of people into the criminal justice system and wastes billions ...

She’s all lazy… and boring.” This image of Sarah, reduced to a mere shell of her former self, was the centerpiece of an anti-marijuana campaign that sought to convey a powerful message ...

Election Day is Tuesday and in four states, voters will have the opportunity to cast their thoughts on the future of marijuana legislation. Here's what to know about marijuana legislation and what ...

Marijuana stocks may seem a tempting investment, but make sure you're aware of the associated risks before diving into this burgeoning market. Many, or all, of the products featured on this page ...

Legalizing marijuana at the national level is generally popular with Americans — 57% of people say marijuana should be legal for both medical and recreational purposes, while 32% say it should ...

Safe weed killers are important in any garden space, but they are even more important in a vegetable garden with crops that ...

This journal utilises an Online Peer Review Service (OPRS) for submissions. By clicking "Continue" you will be taken to our partner site http://www.editorialmanager ...

Opinions expressed by Forbes Contributors are their own. A.J. Herrington is freelance writer covering weed news and culture. Former president and Republican presidential nominee Donald Trump on ...

Marijuana stocks have given cannabis investors nothing but false starts over the past few years. The industry has struggled with a plethora of issues, including inflation, overproduction, lack of ...

Lisa Jarvis is a Bloomberg Opinion columnist covering biotech, health care and the pharmaceutical industry. Previously, she was executive editor of Chemical & Engineering News. Vice President ...